Given the key role of FAK in mesothelioma, especially in merlin-negative cells, it would be interesting to investigate whether modulating RYK expression/activity might influence mesothelioma cell motility and adhesion and/or the proliferation and survival of mesothelioma CSCs derived from NF2−/− tumors. The gene discussed is NF2; the disease is mesothelioma.